BioDisrupt is one of the biofilm disruptors I use most in my practice. Germs in chronic infections build biofilms, slimy matrices of sugars and proteins that hide them from your immune system and blunt herbal and prescription germ killers.

BioDisrupt takes a two-handed approach. The EnzymeDisrupt blend includes serratiopeptidase, lysozyme, and enzymes that digest protein, fat, and fiber, chosen to break down the matrix itself. The HerbDisrupt blend pairs cranberry extract, berberine, rosemary, and peppermint oil, botanicals studied for making it harder for germs to adhere and to communicate through quorum sensing. N-acetyl cysteine adds 300 mg of biofilm-weakening support per capsule.

The research is encouraging. Lab research shows treatment of established biofilm with BioDisrupt resulted in significant reductions in biofilm mass and metabolic activity. The individual ingredients have lab studies behind them too. Serratiopeptidase breaks down biofilm through its proteolytic function, berberine interferes with quorum sensing, and cranberry proanthocyanidins reduce biofilm formation. But nearly all of this is lab work. There are no large human trials in chronic illness. Theory and lab observation support the approach. Definitive in human proof does not exist yet.

I use biofilm disruptors alongside germ killers, not in place of them. When a biofilm opens up, people often experience die-off: more fatigue, headaches, aching. I start low and adjust the pace to how the person responds.

Timing matters with enzymes. The manufacturer directs 2 capsules twice a day between meals, at least two hours after food or one hour before. Taken with a meal, the enzymes digest your food instead of the biofilm. At that dose a 120-capsule bottle is a 30-day supply.

There are cautions worth knowing. The lysozyme comes from egg white, so it is a poor fit with an egg allergy. I do not use it in pregnancy or while nursing, and I review prescription timing with the treating physician.